Axial (A) and coronal (B) T 1 -weighted magnetic resonance images with gadolinium revealing a heterogeneously enhanced lesion in the right temporal lobe. The lesion is attached to the middle fossa floor with contrast enhancement of the adjacent dura mater, but no dural tail sign or extracranial extension is seen. The anteroinferior part consists of a 4-cm solid mass with irregular enhancement adjacent to the middle fossa floor and the posterosuperior part consists of a 3-cm cystic mass with ring-like enhancement. 
Introduction
Gliosarcoma is a rare brain tumor with both gliomatous and sarcomatous components. Recent molecular genetic studies have suggested that these components originate from monoclonal precursor cells. 2) Dural invasion and extracranial metastasis are more common in gliosarcoma than glioblastoma. 9) Here, we report a rare case of gliosarcoma that originated in the temporal lobe, and postoperatively extended into the infratemporal fossa through the middle fossa floor at recurrence, and finally metastasized to the lung.
Case Report
A 51-year-old woman was admitted to our hospital with a 2-month history of headache. Magnetic resonance (MR) imaging revealed an irregular enhanced mass in the right temporal lobe with two components: the anteroinferior part consisted of a 4-cm solid mass with heterogeneous enhancement adjacent to the middle fossa floor, and the posterosuperior part consisted of a 3-cm cystic mass with ring-like enhancement. The dura mater attached to the anteroinferior part showed enhancement, but no dural tail sign or extracranial extension was seen (Fig. 1) .
Gross total removal of the tumor was performed using temporal lobectomy. The anterior part of the tumor was tightly adhered to the dura mater of the middle fossa. A small piece of the invaded dura mater was removed and patched using temporal fascia. No infratemporal tumor growth was identified during surgery. The dura mater was demarcated from the attached tumor and so was not radically excised.
The histological diagnosis was gliosarcoma based on a biphasic pattern consisting of gliomatous and sarcomatous components. The postero-superior part of the tumor was primarily gliomatous, and the antero-inferior part included atypical mesenchymal spindle cell proliferation (Fig. 2B, D) . The tumor attached to the middle fossa floor was exclusively sarcomatous. Ki-67 immunohistochemistry showed the MIB-1 scores were 47.5% for the sarcomatous component and 36.5% for the gliomatous component (Fig. 2E, F) . The patient underwent chemotherapy with intravenous administration of ACNU and local irradiation (60 Gy) to the right temporal region. Follow-up MR imaging revealed a recurrent lesion in the intracranial temporal base after 2 months. Despite additional chemotherapy and irradiation, the tumor grew rapidly, penetrated the middle fossa base, and extended into the infratemporal fossa (Fig. 3) . Furthermore, 4 months after admission, chest computed tomography showed multiple nodular lesions in the right lung indicating metastasis (Fig. 4) . She died of respiratory failure 5 months after the initial diagnosis.
Discussion
Clinical outcome does not significantly differ between gliosarcoma and glioblastoma, 5, 10) possibly because the gliomatous and sarcomatous components of gliosarcoma have a genetically common origin. Patients with highly sarcomatous gliosarcomas have recently survived longer than patients with predominantly gliomatous gliosarcomas. 4, 11) In the present case, the sarcomatous component was predominant but the tumor showed rapid recurrence, with extension into the infratemporal fossa and lung metastasis. Both the disease-free survival time and the actual survival time were extremely short.
Grading systems using the MIB-1 score are strongly prognostic in patients with soft tissue sarcoma of the extremities and trunk. 6) The MIB-1 index of gliosarcomas ranged from 7.7% to 36.1% 7) and was a prognostic factor for glioblastoma. 8) In our case, the MIB-1 score of the sarcomatous component (47.5%) was higher than that of the gliomatous component (36.5%). The most proliferative part of the tumor was present in the sarcomatous component attached to the dura mater of the middle fossa base. The MIB-1 index of this part was 50%. This unusual feature and the severe prognosis were probably caused by the highly proliferative nature of the tumor cells based on the MIB-1 index, particularly in the sarcomatous component adjacent to the temporal base, in addition to the initial infiltrative nature of this tumor.
Extraneural metastases have been described in 11% of previously reported cases of gliosarcoma, most commonly involving the lungs (72%), liver (41%), and lymph nodes (18%). 1, 9) Gliosarcoma tends to disseminate hematogenous metastases more frequently than glioblastoma due to the mesenchymal component. 3) Hematogenous metastases Temporal Gliosarcoma With Extraneural Metastasis may result from invasion of the intratumoral vessels and transdural penetration into the dural sinuses caused by craniotomy procedure or cranial irradiation. 9) Cranial irradiation prolongs survival in patients with glioblastoma, but may also facilitate sarcomatous metaplasia with acquisition of an angioinvasive phenotype. 1, 3) In our case, craniotomy with partial excision of the dura matter and local irradiation may have accelerated tumor penetration through the temporal base and hematogenous metastasis to the lung. The present case suggests that surgeons who identify dural tumor invasion in the temporal base should excise the attached dura as radically as possible with repair of the cranial base to prevent postoperative infratemporal tumor extension and extraneural metastasis.
